- The Dow Jones Industrial Average lost 358.48 points or 1.22%.
- The S&P 500 fell 38.94 points or 1.09%.
- The Nasdaq composite dropped 84.98 points or 0.72%.
US stocks on Wall Street have been tarnished with the surge in US coronavirus cases and the prospects of subsequent lockdowns and harsh economic restriction policies under a Democratic lead White House.
While the news of Pfizer Inc.’s Covid-19 vaccine has been welcomed, the continuing rise in Covid cases weighs on risk sentiment and investors have weighed the timeline for the mass rollout.
The US covid outbreak is uncontrolled throughout all states and we had already started to see a rotation from economic growth stocks back into the stay-at-home choices again on Wednesday.
New York became the latest state to introduce stricter social distancing rules with new infections in the country staying above the psychological 100,000 for an eighth consecutive day.
While the vaccine is on track to be authorized as early as next month, there are still many logistical challenges in getting enough people vaccinated.
Additionally, while new data showed that US jobless claims fell to a seven-month low last week, the pace of job recovery has slowed.
Consequently, the Dow Jones Industrial Average lost 358.48 points, or 1.22%, to 29,039.15, the S&P 500 fell 38.94 points, or 1.09%, to 3,533.72 and the Nasdaq composite dropped 84.98 points, or 0.72%, to 11,701.45.
''The blue-chip Dow DJI was pulled down by industrial and financial companies sensitive to economic growth, with Boeing Co BA and Goldman Sachs GS each down more than 2%,'' Reuters reports.
''Airlines and cruise operators, among the hardest hit by the coronavirus pandemic, also fell.''
However, it is not all bad news for stocks this week and despite the drop today, the S&P 500 has gained almost 2% so far this week.
Stocks are elevated on a weekly basis following the US election result, yet to be officially confirmed, but buoyed on the prospects of a divided Congress.
With the GOP expected to hold the Senate, the new President-elect Joe Biden would be prevented from enacting tax hikes that would hurt corporate profits.
-637408140030558310.png)
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD corrects toward 0.6850, awaits US PCE Price Index
AUD/USD is falling back toward 0.6850 in Friday's Asian trading, reversing from near 19-month peak. A tepid US Dollar bounce drags the pair lower but the downside appears called by the latest Chinese stimulus measures, which boost risk sentiment ahead of US PCE data.
USD/JPY pares gains toward 145.00 after Tokyo CPI inflation data
USD/JPY is paring back gains to head toward 145.00 in the Asian session on Friday, as Tokyo CPI inflation data keep hopes of BoJ rate hikes alive. However, intensifying risk flows on China's policy optimism support the pair's renewed upside. The focus shifts to the US PCE inflation data.
Gold price consolidates below record high as traders await US PCE Price Index
Gold price climbed to a fresh all-time peak on Thursday amid dovish Fed expectations. The USD languished near the YTD low and shrugged off Thursday’s upbeat US data. The upbeat market mood caps the XAU/USD ahead of the key US PCE Price Index.
Avalanche rallies following launch of incentive program for developers
Avalanche announced the launch of Retro9000 on Thursday as part of its larger Avalanche9000 upgrade. Retro9000 is a program designed to support developers with up to $40 million in grants for building on the Avalanche testnet.
RBA widely expected to keep key interest rate unchanged amid persisting price pressures
The Reserve Bank of Australia is likely to continue bucking the trend adopted by major central banks of the dovish policy pivot, opting to maintain the policy for the seventh consecutive meeting on Tuesday.
Five best Forex brokers in 2024
VERIFIED Choosing the best Forex broker in 2024 requires careful consideration of certain essential factors. With the wide array of options available, it is crucial to find a broker that aligns with your trading style, experience level, and financial goals.